GMS Ventures & Investments
CIK 1804598 · last filed 2026-06-01
GMS Ventures & Investments is a corporate insider who has filed 12 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for OTLK, was dated Jun 1, 2026. Across all open-market trades the lifetime net is +$66.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $27.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$26.95M
2
12
$66.72M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | Director | 22,092,068 | $1.22 | $26.95M | $10.00M | 7 | 2026-06-01 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | Director | 27,982,529 | $0.03 | $839.5K | $56.72M | 5 | 2022-02-01 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-01 | OTLK | Mixed | +17,079,418 | $10.00M | EDGAR |
| 2025-03-12 | OTLK | Exer (M) | +6,917,142 | $17.36M | EDGAR |
| 2025-01-22 | OTLK | Mixed | — | $0 | EDGAR |
| 2024-03-20 | OTLK | Grant (A) | +4,611,428 | $0 | EDGAR |
| 2022-12-29 | OTLK | Grant (A) | +28,460,836 | $25.00M | EDGAR |
| 2022-07-07 | OTLK | Other (J) | +55,965,058 | $0 | EDGAR |
| 2022-04-22 | OTLK | Other (J) | +55,965,058 | $0 | EDGAR |
| 2022-02-01 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Other (J) | +5,000,000 | $6.25M | EDGAR |
| 2021-12-01 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Buy (P) | +32,000,000 | $40.00M | EDGAR |
| 2021-02-11 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | +2,027,254 | $2.03M | EDGAR |